October 21, 2016 11:40 PM ET

Company Overview of The Global Alliance for TB Drug Development

Executive Profile

Melvin K. Spigelman M.D.

Chief Executive Officer, President and Director, The Global Alliance for TB Drug Development
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 3 different industries.

See Board Relationships


Dr. Melvin K. Spigelman, also known as Mel, M.D. serves as Chief Executive Officer and President of Global Alliance for TB Drug Development. Dr. Spigelman has been at Global Alliance for TB Drug Development since January 2009 and also serves as a Director. Dr. SpHe igelman served as a Research and Development Director since 2003 at the firm. He serves as a Venture Partner at Wellington Partners Venture Capital GmbH since joining the firm in May 2005 and focuses on the ...

Corporate Headquarters

--, -- --

United States

Phone: --
Fax: --

Board Members Memberships

Chief Executive Officer, President and Director
Independent Director and Member of Audit Committee
Independent Director, Chairman of External Communication Oversight Committee, Member of Audit Committee and Member of Compensation Committee


Brown University
Icahn School of Medicine at Mount Sinai

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact The Global Alliance for TB Drug Development, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.